Literature DB >> 20025951

Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid.

Nan Li1, Qian Su, Fengping Tan, Jerry Zhang.   

Abstract

The objective of this study is to investigate the effect of 1,4-cyclohexanediol as a retardant on the percutaneous absorption and penetration of azelaic acid. Hairless rat skin was mounted on Franz diffusion cells and treated with topical formulations containing solubilized azelaic acid with and without 1,4-cyclohexanediol. The skin was separated into stratum corneum and the deeper skin layers. The azelaic acid collected in receptor medium and each layer at the end of each time point was extracted and quantified. A significant decrease in flux across the skin suggests a penetration retardation effect of 1,4-cyclohexanediol (42.50 microg/cm(2)/h in the presence of vs. 76.25 microg/cm(2)/h in the absence of) at active loading level of 1.13 mg/cm(2). The penetration retardation effect was also observed at higher active loading level (2.82 mg/cm(2)). Furthermore, presence of 1,4-cyclohexanediol in the topical formulation did not reduce the skin and epidermal retention of azelaic acid, suggesting its potential use in the development of superior topical formation for reducing potential systematic side effect while maintaining therapeutic efficiency. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025951     DOI: 10.1016/j.ijpharm.2009.12.025

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Effect of hydrocarbon chain length in 1,2-alkanediols on percutaneous absorption of metronidazole: toward development of a general vehicle for controlled release.

Authors:  Nan Li; Weibu Jia; Yan Zhang; Michelle C Zhang; Fengping Tan; Jerry Zhang
Journal:  AAPS PharmSciTech       Date:  2014-01-07       Impact factor: 3.246

2.  Effect of hydroxyl groups and rigid structure in 1,4-cyclohexanediol on percutaneous absorption of metronidazole.

Authors:  Yan Zhang; Fengping Tan; Weipu Jia; Nan Li; Jerry Zhang
Journal:  AAPS PharmSciTech       Date:  2014-05-13       Impact factor: 3.246

3.  Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.

Authors:  Marian Seif; Michael L Impelido; Michael G Apps; Nial J Wheate
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.